Literature DB >> 8359083

Production of chemoattractant by Helicobacter pylori.

A Reymunde1, J Deren, I Nachamkin, D Oppenheim, G Weinbaum.   

Abstract

Helicobacter pylori is present in the antral region of the stomach in a majority of patients with gastritis type B. The specific mechanism whereby the organism participates in the development of disease remains uncertain. Since the organism is not invasive, we postulate that H. pylori produces a chemoattractant that recruits inflammatory cells to the antral region of the stomach. H. pylori was grown under microaerophilic conditions at 37 degrees C for 72 hr in Brucella broth containing 1% fetal bovine serum. Culture supernates were harvested after removal of organisms by centrifugation and filtration. The putative chemoattractant in culture supernates as well as that which might be present endogenously in the growth medium (negative control) was assayed against human neutrophils (PMN) in modified Boyden blind-well chambers using 3.0-microns membranes. We found that H. pylori supernates are chemotactic and showed up to 130% activity when compared to the positive chemoattractant control (zymosan-activated serum, a source of C5a). Minimal activity was observed with virgin growth medium. The chemoattractant activity is proportional to the number of colony forming units (CFU) of H. pylori. Preliminary characterization of the activity shows that the chemoattractant is stable in a boiling water bath for 15 min, activity is lost within 1 hr in acid or alkali, and the chemotactic factor has an approximate molecular weight of 8500 daltons. The factor has no amino-sugar and is negative for the lipid A portion of lipopolysaccharide.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359083     DOI: 10.1007/bf01303180

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leucocytes and monocytes.

Authors:  H Nielsen; L P Andersen
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

Review 2.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

3.  Possible role of leukotrienes in gastritis associated with Campylobacter pylori.

Authors:  T Fukuda; S Kimura; T Arakawa; K Kobayashi
Journal:  J Clin Gastroenterol       Date:  1990       Impact factor: 3.062

4.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

Review 5.  Chemotactic peptides. Mechanisms, functions, and possible role in inflammatory bowel disease.

Authors:  C C Nast; L E LeDuc
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

6.  Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils.

Authors:  P M Craig; M C Territo; W E Karnes; J H Walsh
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

Review 7.  Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation.

Authors:  M J Blaser
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

8.  Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa.

Authors:  C S Goodwin; R K McCulloch; J A Armstrong; S H Wee
Journal:  J Med Microbiol       Date:  1985-04       Impact factor: 2.472

Review 9.  Campylobacter pylori and peptic ulcer disease.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

10.  Isolation and characterization of Campylobacter pyloridis from gastric biopsies.

Authors:  D E Taylor; J A Hargreaves; L K Ng; R W Sherbaniuk; L D Jewell
Journal:  Am J Clin Pathol       Date:  1987-01       Impact factor: 2.493

View more
  8 in total

1.  Studies on the gastric mucosal microcirculation. 2. Helicobacter pylori water soluble extracts induce platelet aggregation in the gastric mucosal microcirculation in vivo.

Authors:  N Kalia; S Jacob; N J Brown; M W Reed; D Morton; K D Bardhan
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

2.  Toxigenic Helicobacter pylori induces changes in the gastric mucosal microcirculation in rats.

Authors:  N Kalia; K D Bardhan; J C Atherton; N J Brown
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

3.  Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo.

Authors:  N Kalia; K D Bardhan; M W Reed; S Jacob; N J Brown
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

4.  Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo.

Authors:  N Kalia; K D Bardhan; M W Reed; S Jacob; N J Brown
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

5.  Characterization of a Helicobacter pylori neutrophil-activating protein.

Authors:  D J Evans; D G Evans; T Takemura; H Nakano; H C Lampert; D Y Graham; D N Granger; P R Kvietys
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

6.  Occurrence of gastric ulcers in gnotobiotic piglets colonized by Helicobacter pylori.

Authors:  S Krakowka; K A Eaton; D M Rings
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor.

Authors:  B Satin; G Del Giudice; V Della Bianca; S Dusi; C Laudanna; F Tonello; D Kelleher; R Rappuoli; C Montecucco; F Rossi
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

8.  Treatment of Helicobacter pylori infected mice with Bryophyllum pinnatum, a medicinal plant with antioxidant and antimicrobial properties, reduces bacterial load.

Authors:  Laure Brigitte Kouitcheu Mabeku; Bertrand Eyoum Bille; Thibau Flaurant Tchouangueu; Eveline Nguepi; Hubert Leundji
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.